Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biomed Pharmacother ; 130: 110603, 2020 Oct.
Article in English | MEDLINE | ID: mdl-34321164

ABSTRACT

Leptadenia arborea (Asclepiadaceae) is a plant used in traditional medicine to treat syphilis, migraine, and mental illnesses. The aim of our study was to investigate possible antidepressant and anti-amnesic effects of the aqueous lyophilisate of the leaves of Leptadenia arborea in an animal model of cognitive deficit associated depression. Swiss albino adult mice of both sexes were used for this study. A 14-day combined stress model was used to induce depression with early cognitive deficits. The forced swimming test, the open field test and plasma corticosterone level were used to assess antidepressant-like effect. The novel object recognition task (NORT), the Morris Water Maze (MWM) and neurochemical analysis of hippocampal acetylcholinesterase activity was also carried out to assess memory integrity. The aqueous lyophelisate of L. arborea increased swimming time and decreased immobility time in the forced swimming test. In the open field test they was no difference in the number of lines crossed between groups, and the lyophilisate-treated mice spent more time in the centre compared to the control. The lyophilisate decreased the plasma level of corticosterone compared to the control. The lyophilisate decreased the latency to reach the hidden platform and increased the time spent in the target quadrant in the MWM. The lyophilisate also increased the time of exploration of the novel object in the NORT and decreased the acetylcholinesterase activity in the hippocampus. L. arborea effects were decreased when it was co-administered with pCPA. Results suggest that the aqueous lyophilisate of the leaves of L. arborea possess antidepressant-like and anti-amnesic effects.


Subject(s)
Antidepressive Agents/pharmacology , Apocynaceae/chemistry , Cognitive Dysfunction/drug therapy , Depression/drug therapy , Depression/psychology , Plant Extracts/pharmacology , Amnesia/drug therapy , Animals , Antidepressive Agents/chemistry , Behavior, Animal , Biomarkers , Cognition/drug effects , Disease Models, Animal , Maze Learning , Mice , Plant Extracts/chemistry , Plant Leaves/chemistry
2.
Biomed Pharmacother ; 91: 350-357, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28463798

ABSTRACT

Learning and memory are the most important executive functions performed by the human brain, the loss of which is a prominent feature in dementia. Gladiolus dalenii is traditionally used to treat a number of illnesses such as epilepsy and schizophrenia in Cameroon. This study aims to investigate the anti-amnesia effect of Gladiolus dalenii in scopolamine-induced amnesia in rats and its possible antioxidant properties in this model. Morris water maze, novel object location and recognition tasks were used to assess spatial and working memory. Male rats were treated for 12 days with saline, G. dalenii or Tacrine. Experimental animals were co-treated with scopolamine once daily from day 9 to 12. Acetylcholinesterase activity was measured in the prefrontal cortex and hippocampus. Malondialdehyde and glutathione levels were measured in the hippocampus. G. dalenii reversed memory impairment induced by scopolamine in the Morris water maze, novel object location and recognition tasks. It decreased acetylcholinesterase activity in the hippocampus and prefrontal cortex. It also decreased the level of malondialdehyde and increased the level of glutathione in the hippocampus. The results of this study show that G. dalenii ameliorates the cognitive impairment induced by scopolamine, through inhibition of oxidative stress and enhancement of cholinergic neurotransmission. It can therefore be useful for treatment of conditions associated with memory dysfunction as seen in dementia.


Subject(s)
Amnesia/chemically induced , Amnesia/drug therapy , Brain/pathology , Freeze Drying , Iridaceae/chemistry , Oxidative Stress , Plant Extracts/therapeutic use , Acetylcholinesterase/metabolism , Animals , Glutathione/metabolism , Hippocampus/drug effects , Hippocampus/enzymology , Hippocampus/metabolism , Hippocampus/pathology , Male , Malondialdehyde/metabolism , Maze Learning/drug effects , Memory/drug effects , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Prefrontal Cortex/drug effects , Prefrontal Cortex/embryology , Prefrontal Cortex/pathology , Rats, Wistar , Recognition, Psychology , Scopolamine , Task Performance and Analysis
3.
Behav Neurol ; 2017: 5952897, 2017.
Article in English | MEDLINE | ID: mdl-28386162

ABSTRACT

Aim. To assess memory improvement and neuroprotective and antioxidant effects of Mitragyna inermis (M. inermis) leaf decoction on the central nervous system. Methodology. Leaf decoction of M. inermis was tested on learning and memory in normal and scopolamine-induced cognitive impairment in mice using memory behavioral tests such as the Morris water maze, object recognition task, and elevated plus maze. Oxidative stress enzymes-catalase, superoxide dismutase, and the thiobarbituric acid reactive substance, a product of lipid peroxidation-were quantified. In each test, mice 18 to 25 g were divided into groups of 5. Results. The extract reversed the effects of scopolamine in mice. The extract significantly increased discrimination index in the object recognition task test and inflexion ratio in the elevated plus maze test. The times spent in target quadrant in MWM increased while the transfer latency decreased in mice treated by M. inermis at the dose of 196.5 mg/kg. The activity levels of superoxide dismutase and catalase were significantly increased, whereas the thiobarbituric acid reactive substance was significantly decreased after 8 consecutive days of treatment with M. inermis at the dose of 393 mg/kg. Conclusion. These results suggest that M. inermis leaf extract possess potential antiamnesic effects.


Subject(s)
Memory Disorders/drug therapy , Memory/drug effects , Mitragyna/chemistry , Plant Preparations/pharmacology , Animals , Antioxidants/pharmacology , Brain/drug effects , Brain/metabolism , Female , Hippocampus/drug effects , Hippocampus/metabolism , Male , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/metabolism , Mice , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Plant Leaves/chemistry , Scopolamine
SELECTION OF CITATIONS
SEARCH DETAIL
...